Replay from one of my earlier posts following today's Fox show (couple of minor corrections/additions as I feel this is important for CytoDyn ):
Repeatedly our CEO stated no side effects which is a great point to drill home... there are strategic ways to bring out the message in our story in these short interviews... just the highlights and facts please:
1. Leronlimab is being used and 4 or however many severely ill Covid-19 patients have been taken off respirators or extubated.
2. Leronlimab is being used and moderately ill patients are being successfully treated (and maybe some going home? how many treated? how many discharged? )
3. Our drug is being used at the prestigious Montifiore Medical Center in New York City by Dr. Harish Seethamraju. Many thanks to him and the center.
4. There are (apparently) no negative side effects from Leronlimab which is unlike any other known drug to date ??
5. The time of treatment or removal from a respirator is (however many days, ie: 3-7 days etc.)
6. The treatment process is via (one or two or however many) injections (or whatever).
7. Leronlimab is a drug we've been testing/using on HIV patients (840?) for the past five-plus years with no side effects... (or whatever the numbers and facts).
8. Leronlimab is a drug we've tested or is under trial for cancer and treats/helps patients with various cancer - 22 types of cancer or however many.
Please Dr. Pourhassan speak about Leronlimab and its benefits in this terminology which would be understood by all...
This is how a press release to non-business media/newspapers could go out or our CEO should spell out to regular folks or the general public.
With a press release like this even the host/interviewer whoever they are will get it... and express themselves with more knowledge.
Unfortunately this short chat did not quite hit the mark today but hopefully now other network/cable/national/international NEWS media will jump on board...
Read More: https://investorshangout.com/post/view?id=572...z6IxgioBTr
Remember this is a short week for the markets with just two more working days but a long weekend for CytoDyn to continue spreading the word (not necessarily publicly but surely there are plenty of institutions and impactful people who are contacting Dr. Pourhassan and others involved with Leronlimab to get information/help from for COVID-19 patients).
On a personal note, today I heard of three family members of three of my friends passing away from this plague... one of them a strong 55-year-old man who lived in the Bronx but not sure he was at Montifiore in the Bronx... no he was not one of the very few lucky ones at the medical center to have received Leronlimab unfortunately.
Please forgive lengthy post
Be well, stay safe and very best to all with CYDY !
Repeatedly our CEO stated no side effects which is a great point to drill home... there are strategic ways to bring out the message in our story in these short interviews... just the highlights and facts please:
1. Leronlimab is being used and 4 or however many severely ill Covid-19 patients have been taken off respirators or extubated.
2. Leronlimab is being used and moderately ill patients are being successfully treated (and maybe some going home? how many treated? how many discharged? )
3. Our drug is being used at the prestigious Montifiore Medical Center in New York City by Dr. Harish Seethamraju. Many thanks to him and the center.
4. There are (apparently) no negative side effects from Leronlimab which is unlike any other known drug to date ??
5. The time of treatment or removal from a respirator is (however many days, ie: 3-7 days etc.)
6. The treatment process is via (one or two or however many) injections (or whatever).
7. Leronlimab is a drug we've been testing/using on HIV patients (840?) for the past five-plus years with no side effects... (or whatever the numbers and facts).
8. Leronlimab is a drug we've tested or is under trial for cancer and treats/helps patients with various cancer - 22 types of cancer or however many.
Please Dr. Pourhassan speak about Leronlimab and its benefits in this terminology which would be understood by all...
This is how a press release to non-business media/newspapers could go out or our CEO should spell out to regular folks or the general public.
With a press release like this even the host/interviewer whoever they are will get it... and express themselves with more knowledge.
Unfortunately this short chat did not quite hit the mark today but hopefully now other network/cable/national/international NEWS media will jump on board...
Read More: https://investorshangout.com/post/view?id=572...z6IxgioBTr
Remember this is a short week for the markets with just two more working days but a long weekend for CytoDyn to continue spreading the word (not necessarily publicly but surely there are plenty of institutions and impactful people who are contacting Dr. Pourhassan and others involved with Leronlimab to get information/help from for COVID-19 patients).
On a personal note, today I heard of three family members of three of my friends passing away from this plague... one of them a strong 55-year-old man who lived in the Bronx but not sure he was at Montifiore in the Bronx... no he was not one of the very few lucky ones at the medical center to have received Leronlimab unfortunately.
Please forgive lengthy post
Be well, stay safe and very best to all with CYDY !
4
